Centre for Cancer Research and Cell Biology

      1. Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation

        Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)

        Impact: Health Impact, Quality of Life Impact

      2. Identifying Patients with Rare Forms of Erythrocytosis

        Mary Frances McMullin (Participant), Terence Lappin (Participant), Anne Hughes (Participant)

        Impact: Health Impact, Quality of Life Impact

      3. Successful Commercial Exploitation of Digital Pathology for Cancer Education, Biomarker Discovery and Clinical Diagnosis

        Peter Hamilton (Participant), James Diamond (Participant), Yinhai Wang (Participant), Ching-Wei Wang (Participant), Paul Kelly (Participant), Jacqueline James (Participant), Dean Fennell (Participant)

        Impact: Health Impact, Quality of Life Impact